ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Biohaven's Verdiperstat Receives Fast Track Designation for Multiple System Atrophy Treatment
March 19, 2020Biohaven Pharmaceutical announced the Company's myeloperoxidase (MPO) inhibitor, verdiperstat, received Fast Track designation from the US Food and Drug Administration (FDA) ... -
Verdiperstat Receives Orphan Drug Designation from FDA for Multiple System Atrophy
February 20, 2019Biohaven announced it received orphan drug designation from the U.S. Food and Drug Administration (FDA) for its product candidate verdiperstat (previously BHV-3241)....
Pharma Sources Insight January 2025
